Amneal Pharmaceuticals, Inc. AMRX

This is a cheap item with several competitors. With larger companies giving it to countries, all Amneal can do, is give it away also. Actually hurts them, not help them.

Not so sure acquisitions are a good thing, when you have very little cash, and almost 3 billion in debt. They should be concentrating on bringing down their debt, not getting more in debt. One step closer to bankruptcy in my opinion.

With only 50 million in the bank, and almost 3 billion in debt, I don’t see how this is ever gonna get turned around. If the founders can’t fix this quick, it’s lights out!!